Companies
- Companies
- Browse
Companies
The primary therapeutic areas being focused upon are cardiovascular and related conditions (e.g. diabetes), anti-inflammatory conditions (R.A), dermatology and ophthalmology. More
Sankyo Co. Ltd. is currently the second largest pharmaceutical company in Japan. It is famous as the founder of HMG-CoA reductase inhibitor anti-hyperlipidemia drugs. More
The company has evolved into producer of pharmaceuticals, agrochemicals, advanced materials, household products, processed plastic products, and related machines and systems More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 40 pages - $500
Mar 2009 - 20 pages - $995
Mar 2011 - 34 pages - $1,000
Jun 2009 - 37 pages - $995
Oct 2005 - 10 pages - $1,100
Dec 2010 - 84 pages - $500
Oct 2010 - 169 pages - $3,500
Jul 2011 - 4 pages - $10,000
Feb 2005 - 16 pages - $1,800
Nov 2011 - 7 pages - $3,835
Your selection
Browse By
- Industry sector
- Academic/Research
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Non-profit org./Government
- Pharmaceutical
- Research tools
- Service
- Therapeutic target
- Age-related disorders (other)
- Back pain
- Birth defects
- Bone cancer
- Chronic granulomatous disease
- Dupuytren's disease
- Dyskinesia
- Fibrocystic breast disease
- Gout
- Growth disorders
- Hypomobility
- Intermittent claudication
- Leprosy
- Lupus erythematosis
- Muscular
- Musculoskeletal disorder (other)
- Scleroderma
- Sjogren's syndrome
- Skeletal
- Trauma, physical
- Wasting disease
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us